Chinese Journal of Blood Purification ›› 2023, Vol. 22 ›› Issue (04): 292-295.doi: 10.3969/j.issn.1671-4091.2023.04.010

Previous Articles     Next Articles

Research progresses in the pH-neutral, low-glucose degradation product dialysates for peritoneal dialysis 

WU Hai-shan, MAO Hai-ping, CHEN Wei, YANG Xiao   

  1. Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University; 2Key Laboratory of Nephrology, Ministry of Health, Guangzhou 510080, China
  • Received:2022-12-08 Revised:2022-12-22 Online:2023-04-12 Published:2023-04-12
  • Contact: 510080 广州,1中山大学附属第一医院肾内科 2卫健委和广东省重点实验室 E-mail:yxiao@mail.sysu.edu.cn

Abstract: Conventional glucose-based peritoneal dialysates with higher glucose concentrations, high glucose degradation products, advanced glycation end products and lower pH have been recognized as bio-incompatible, affecting peritoneal dialysis efficacy and leading to technique failure. pH-neutral, low-glucose degradation product dialysates are relatively biocompatible, and are thought to be superior to the conventional dialysates especially in long-term use of peritoneal dialysis. In this paper, we review the recent advances in pH-neutral, low-glucose degradation product dialysates on the residual renal function, peritoneal function, peritonitis rate, patient and technique survival, and peritoneum pathology in peritoneal dialysis patients.

Key words: Peritoneal dialysis, End stage renal disease, pH-neutral, low-glucose degradation product solution

CLC Number: